Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis
- PMID: 32941525
- PMCID: PMC7498091
- DOI: 10.1371/journal.pone.0239295
Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis
Abstract
Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer, particularly in ulcerative colitis (UC) when the majority of colon epithelial cells may be exposed to inflammation-associated mutagenesis. In addition to mutagenesis generated by oxidative stress, inflammation can induce activation-induced cytidine deaminase (Aicda), a mutator enzyme in the APOBEC family, within colon epithelial cells. This study tested the hypothesis that deletion of the Aicda gene could protect against the development of inflammation-associated colorectal cancers, using a model of UC-like colitis in "T/I" mice deficient in TNF and IL10. Results showed that T/I mice that were additionally Aicda-deficient ("TIA" mice) spontaneously developed moderate to severe UC-like colitis soon after weaning, with histologic features and colon inflammation severity scores similar those in T/I mice. Although the mean survival of TIA mice was decreased compared to T/I mice, multivariable analysis that adjusted for age when neoplasia was ascertained showed a decreased numbers of neoplastic colorectal lesions in TIA mice, with a trend toward decreased incidence of neoplasia. Aicda deficiency increased serum IL1α and slightly decreased IL12p40 and M-CSF, as compared with T/I mice, and led to undetectable levels of IgA, IgG1, IgG2a, IgG2b, and IgG3. Taken together, these studies show that Aicda deficiency can decrease the number of neoplastic lesions but is not sufficient to prevent the risk of inflammation-associated colorectal neoplasia in the setting of severe UC-like inflammation. The TIA model may also be useful for assessing the roles of antibody class-switch recombination deficiency and somatic hypermutation on regulation of microbiota and inflammation in the small intestine and colon, as well as the pathogenesis of colitis associated with hyper-IgM syndrome in humans. Further studies will be required to determine the mechanisms that drive early mortality in TIA mice.
Conflict of interest statement
The author has declared that no competing interests exist.
Figures
Similar articles
-
Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers.J Gastroenterol. 2011 Jan;46 Suppl 1:6-10. doi: 10.1007/s00535-010-0326-1. Epub 2010 Sep 28. J Gastroenterol. 2011. PMID: 20878190
-
A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features.PLoS One. 2012;7(7):e41797. doi: 10.1371/journal.pone.0041797. Epub 2012 Jul 27. PLoS One. 2012. PMID: 22848611 Free PMC article.
-
Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation.Oncogene. 2012 Mar 29;31(13):1733-42. doi: 10.1038/onc.2011.352. Epub 2011 Aug 15. Oncogene. 2012. PMID: 21841819
-
Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models.Carcinogenesis. 2003 Mar;24(3):353-62. doi: 10.1093/carcin/24.3.353. Carcinogenesis. 2003. PMID: 12663492 Review.
-
A comprehensive review and update on ulcerative colitis.Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2. Dis Mon. 2019. PMID: 30837080 Review.
Cited by
-
Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis.Microorganisms. 2021 Oct 8;9(10):2117. doi: 10.3390/microorganisms9102117. Microorganisms. 2021. PMID: 34683438 Free PMC article. Review.
References
-
- Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18: 1–5. - PubMed
-
- Nordenholtz KE, Stowe SP, Stormont JM, Stowe MM, Chessin LN, Shah AN, et al. The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York. Am J Gastroenterol. 1995;90: 927–932. - PubMed
-
- Soderlund S, Brandt L, Lapidus A, Karlen P, Brostrom O, Lofberg R, et al. Gastroenterol. 2009;136: 1561–1567. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous